Details for New Drug Application (NDA): 017027
✉ Email this page to a colleague
The generic ingredient in LIPO-HEPIN is heparin sodium. There are seventy-seven drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the heparin sodium profile page.
Summary for 017027
Tradename: | LIPO-HEPIN |
Applicant: | 3m |
Ingredient: | heparin sodium |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 1,000 UNITS/0.5ML | ||||
Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 5,000 UNITS/0.5ML | ||||
Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 10,000 UNITS/0.5ML | ||||
Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No |
Complete Access Available with Subscription